We are excited to be speaking at the CASSS Cell and Gene Therapy Products Europe, in Lisbon, Portugal, this October.
The Symposium brings together industry, regulatory, and academic professionals to explore how to continue adapting concepts derived from other biologics specifically to CGTP and how to establish novel approaches where they are needed. The three-day program features a keynote presentation, speaker presentations, panel discussions, roundtables, and networking opportunities that allow you to engage in meaningful discussions on the latest updates and challenges regarding CGTP in Europe and globally.
Hear live from us
Plenary Session 1 - Innovative Strategies and Tools to Improve CGT Development and Manufacturing
Date and time: 10:25 - 12:10 Tuesday, 20th October, 2026
Location: Europa | Floor -1
Track: CGTP Europe Symposium
Title: CERSI‑AT: Practical Guidance for Decentralized Manufacturing
Speaker: Roumyana Kotopanova, Regulatory Affairs Manager and Rehma Chandaria, Head of Regulatory Affairs
Roundtable Discussions | Session I
Date and time: 15:25 - 16:25 Tuesday, 20th October, 2026
Location: Roma | Floor 1
Table 6 - Breaking Down Silos in Technology and Knowledge Transfer
Speaker: Roumyana Kotopanova, Regulatory Affairs Manager
Plenary Session 5 - Individualized Cell and Gene Therapies: Navigating the Path Toward Personalized Medicines
Date and time: 15:05 - 16:50 Wednesday, 21st October, 2026
Location: Europa | Floor -1
Title: Regulatory Flexibilities and Their Impact on Ultra Rare Disease Therapy Development
Speaker: Christopher Rogers, Senior Regulatory Affairs Manager